ProQR Therapeutics N.V. (FRA:0PQ)
1.783
+0.103 (6.13%)
Last updated: Dec 5, 2025, 8:02 AM CET
ProQR Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -42.57 | -27.76 | -28.12 | -64.42 | -60.74 | -46.57 | Upgrade
|
| Depreciation & Amortization | 2.7 | 2.76 | 2.51 | 2.52 | 2.33 | 2.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.13 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.51 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.01 | 0.22 | 0.32 | Upgrade
|
| Stock-Based Compensation | 3.35 | 2.54 | 3.11 | 2.87 | 6.22 | 7.84 | Upgrade
|
| Other Operating Activities | -0.74 | -0.67 | -4.78 | -4.49 | 1.47 | -5.54 | Upgrade
|
| Change in Unearned Revenue | -12.73 | -12.73 | -6.47 | -2.99 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 1.21 | -0.54 | 55.43 | -2 | 25.01 | -5.47 | Upgrade
|
| Operating Cash Flow | -48.78 | -36.39 | 21.55 | -68.51 | -26.01 | -47.06 | Upgrade
|
| Capital Expenditures | -0.63 | -1.42 | -1.37 | -0.71 | -0.48 | -0.92 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.06 | 0.01 | 0.06 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | 7.94 | - | - | - | Upgrade
|
| Other Investing Activities | -2.66 | -2.66 | -2.35 | - | - | - | Upgrade
|
| Investing Cash Flow | -3.28 | -4.07 | 4.28 | -0.7 | -0.43 | -0.92 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 27.66 | 14.37 | Upgrade
|
| Long-Term Debt Repaid | - | -1.58 | -2.63 | -45.05 | -0.82 | -0.61 | Upgrade
|
| Net Debt Issued (Repaid) | -1.56 | -1.58 | -2.63 | -45.05 | 26.84 | 13.77 | Upgrade
|
| Issuance of Common Stock | 71.75 | 71.86 | 0.35 | 14.16 | 110 | 0.74 | Upgrade
|
| Financing Cash Flow | 70.19 | 70.28 | -2.28 | -30.89 | 136.83 | 14.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.65 | 0.67 | 0.6 | 7.35 | 1.29 | -2.63 | Upgrade
|
| Net Cash Flow | 17.48 | 30.48 | 24.15 | -92.75 | 111.69 | -36.11 | Upgrade
|
| Free Cash Flow | -49.41 | -37.81 | 20.18 | -69.22 | -26.5 | -47.98 | Upgrade
|
| Free Cash Flow Margin | -307.38% | -193.46% | 305.99% | -1587.89% | -1114.21% | -4663.17% | Upgrade
|
| Free Cash Flow Per Share | -0.48 | -0.44 | 0.25 | -0.97 | -0.41 | -0.96 | Upgrade
|
| Cash Interest Paid | 0.58 | 0.77 | 0.79 | 3.76 | 2.25 | 1.11 | Upgrade
|
| Cash Income Tax Paid | 0.02 | -0.2 | -0.08 | 0.1 | 0.12 | 0.19 | Upgrade
|
| Levered Free Cash Flow | -31.54 | -18.04 | 62.8 | -99.16 | -16.21 | -27.45 | Upgrade
|
| Unlevered Free Cash Flow | -30.87 | -17.37 | 63.56 | -95.96 | -14.09 | -26.18 | Upgrade
|
| Change in Working Capital | -11.52 | -13.26 | 48.96 | -4.99 | 25.01 | -5.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.